{"transactions":[{"id":735093,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":37454,"kind":"person","name":"Joustra Wouter","position":1,"cik":"0001897813","reported_name":"Joustra Wouter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T21:37:15.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on the earlier of (i) the first anniversary of the vesting commencement date, which was June 9, 2026 or (ii) the registrant's 2027 annual meeting of shareholders."}],"balance_after":31000,"derivative":{"exercise_price":1.75,"expiration_date":"2036-06-16","underlying":"Common Shares","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0000929638-26-002257","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897813/000092963826002257/form4.xml","form_type":"4"}},{"id":740723,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":37454,"kind":"person","name":"Joustra Wouter","position":1,"cik":"0001897813","reported_name":"Joustra Wouter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-13T00:41:39.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":57162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth of the shares subject to the option shall vest and become exercisable on July 11, 2026 and each month thereafter, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":57162,"derivative":{"exercise_price":14.09,"expiration_date":"2036-06-10","underlying":"Common stock","underlying_shares":57162},"source":{"system":"sec-edgar","filing":"0001193125-26-269999","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897813/000119312526269999/ownership.xml","form_type":"4"}},{"id":962560,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":37454,"kind":"person","name":"Joustra Wouter","position":1,"cik":"0001897813","reported_name":"Joustra Wouter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T23:17:24.000Z","date":"2025-12-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest and become exercisable in a series of 36 successive equal monthly installments beginning on December 18, 2025, in each case subject to the Reporting Person's continued service as of each such date."}],"balance_after":3000,"derivative":{"exercise_price":12.8,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001897813-25-000010","document":"form4-12192025_111221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897813/000189781325000010/form4-12192025_111221.xml","form_type":"4"}},{"id":1110436,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":37454,"kind":"person","name":"Joustra Wouter","position":1,"cik":"0001897813","reported_name":"Joustra Wouter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T22:39:30.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option fully vests on the earlier of (i) the first anniversary of the date vesting commenced, which was June 10, 2025; or (ii) the 2026 Annual Meeting of Shareholders."}],"balance_after":22500,"derivative":{"exercise_price":3.31,"expiration_date":"2035-06-16","underlying":"Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000929638-25-002251","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897813/000092963825002251/form4.xml","form_type":"4"}},{"id":1476270,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":37454,"kind":"person","name":"Joustra Wouter","position":1,"cik":"0001897813","reported_name":"Joustra Wouter","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-18T20:08:01.000Z","date":"2024-06-15","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests at 1/3 on each of the first, second and third anniversaries of the date vesting commenced, which was May 15, 2024."}],"balance_after":40000,"derivative":{"exercise_price":9,"expiration_date":"2034-06-15","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000929638-24-002215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1897813/000092963824002215/form4.xml","form_type":"4"}}]}